These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5856119)

  • 1. Evaluation and selection of patients for "substitutive-inhibitory therapy" in thalassemia and sickle cell disease.
    Rewald E
    Isr J Med Sci; 1965 Jul; 1(4):782-3. PubMed ID: 5856119
    [No Abstract]   [Full Text] [Related]  

  • 2. [Substitutive-inhibitory transfusion in severe erythropathies].
    Rewald E
    Med Klin; 1965 Jul; 60(28):1117-22. PubMed ID: 5835981
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
    Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
    Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of thalassemia and sickle cell anemia in children].
    Girot R
    Ann Pediatr (Paris); 1978; 25(5-6):277-84. PubMed ID: 16114336
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia.
    Vichinsky E; Butensky E; Fung E; Hudes M; Theil E; Ferrell L; Williams R; Louie L; Lee PD; Harmatz P
    Am J Hematol; 2005 Sep; 80(1):70-4. PubMed ID: 16138345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
    Fathallah H; Sutton M; Atweh GF
    Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects of different types of red cell concentrates in patients with thalassemia and sickle cell disease.
    Cabibbo S; Fidone C; Antolino A; Manenti OG; Garozzo G; Travali S; Bennardello F; Di Stefano R; Bonomo P
    Transfus Clin Biol; 2007 Dec; 14(6):542-50. PubMed ID: 18434227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia.
    Flanagan JM; Steward S; Hankins JS; Howard TM; Neale G; Ware RE
    Am J Hematol; 2009 Jun; 84(6):328-34. PubMed ID: 19384939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
    Pakbaz Z; Fischer R; Fung E; Nielsen P; Harmatz P; Vichinsky E
    Pediatr Blood Cancer; 2007 Sep; 49(3):329-32. PubMed ID: 17554789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future.
    Bhatia M; Walters MC
    Bone Marrow Transplant; 2008 Jan; 41(2):109-17. PubMed ID: 18059330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-thalassemia and sickle cell disease in culture of early erythroid precursors: hemoglobin synthesis and ultrastructural study.
    Beuzard Y; Tulliez M; Testa U; Vainchenker W; Dubart A; Tsapis A; Galacteros F; Breton-Gorius J; Rosa J
    Blood Cells; 1981; 7(1):179-200. PubMed ID: 7187747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of sickle cell disease].
    Aluoch JR
    Ned Tijdschr Geneeskd; 1984 Jun; 128(25):1187-90. PubMed ID: 6462265
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gene therapy: from fiction to reality?].
    Wagemaker G
    Ned Tijdschr Geneeskd; 1987 Oct; 131(44):1986-7. PubMed ID: 3479699
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels.
    Karam LB; Disco D; Jackson SM; Lewin D; McKie V; Baker RD; Baker SS; Laver JH; Nietert PJ; Abboud MR
    Pediatr Blood Cancer; 2008 Jan; 50(1):62-5. PubMed ID: 17457853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy and sickle cell hemoglobinopathies: results with and without prophylactic transfusions.
    Cunningham FG; Pritchard JA; Mason R
    Obstet Gynecol; 1983 Oct; 62(4):419-24. PubMed ID: 6888818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical management and prevention guidelines for children with sickle cell disease.
    Wang W; Day S; Turner E; Bhakta M; Erickson S
    J Tenn Med Assoc; 1992 May; 85(5):209-14. PubMed ID: 1583891
    [No Abstract]   [Full Text] [Related]  

  • 17. Iron loading and endocrine functions in nontransfused patients with beta-thalassemia intermedia or sickle-cell thalassemia.
    Flatau E; Resnitzky P; Kauffman N; Harpaz S; Kohn D
    Isr J Med Sci; 1981 Jan; 17(1):22-7. PubMed ID: 7461943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy for thalassemia and sickle-cell disease].
    Dickerhoff R
    Dtsch Med Wochenschr; 2015 Nov; 140(22):1646. PubMed ID: 26536632
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythrocytapheresis (red cell exchange).
    Sentinella K; Thompson R; Hunt D; Simpson L; Marshall CE
    Prog Clin Biol Res; 1982; 106():425-35. PubMed ID: 7178144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron overload in thalassemia and sickle cell disease.
    Taher A
    Semin Hematol; 2005 Apr; 42(2 Suppl 1):S5-9. PubMed ID: 15846583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.